NCT06934551 Patient Satisfaction & Abutment Teeth Health in Maxillectomy Patients
| NCT ID | NCT06934551 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Maxillary Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-12-10 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-12-10 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
randomized controlled trial in maxillectomy patients with two types of obturators with different manufacturing techniques
Eligibility Criteria
Inclusion Criteria * Patients with hemi maxillectomy * Sufficient number of natural teeth not less than 5 teeth * Age between 30 and 60 years * Intact soft palate Exclusion Criteria * Cognitive impairment * Heavy smokers * Patients exposed to radiotherapy
Frequently Asked Questions
Who can join the NCT06934551 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 60 Years, studying Maxillary Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06934551 currently recruiting?
Yes, NCT06934551 is actively recruiting participants. Visit ClinicalTrials.gov or contact Cairo University to inquire about joining.
Where is the NCT06934551 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06934551 clinical trial?
NCT06934551 is sponsored by Cairo University. The trial plans to enroll 20 participants.